Clinical trial · Observational
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry
NCT01439698CI-TRIAL-00026054RFA-RegistryunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this protocol is to establish a multicenter registry to evaluate the impact of radiofrequency ablation in the management of patients with pancreatico-biliary disorders including malignancies.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bile Duct Cancer | Malignant Bile Duct Neoplasm | CURATED_BROADER | 0.80 |
| Bile Duct Obstruction | — | UNRESOLVED | — |
| Biliary Stricture | — | UNRESOLVED | — |
| Cholangiocarcinoma | Cholangiocarcinoma | ONTOLOGY_EXACT | 0.98 |
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Radio Frequency ablation Probe | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- RFA for Pancreatico-biliary disorders
- description
- Subjects who will receive radiofrequency ablation for pancreatico-biliary disorders, including malignancies.
- interventionNames
- Device: Radio Frequency ablation Probe
Primary outcomes (2)
- measure
- Change from Baseline in Bile Duct Stricture Diameter.
- timeFrame
- 4 years
- description
- Efficacy Assessment- Change from Baseline in Bile Duct Stricture Diameter.
- measure
- Number of Participants with Adverse Events
- timeFrame
- 4 years
- description
- Safety Assessment - Number of Participants with Adverse Events, type, frequency and intensity.
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients who have undergone RFA for pancreaticobiliary disorders * Above 18 years of age Exclusion Criteria: * Patients who have not undergone RFA * Below 18 years of age
References
Publications (1)
- RESULTSharaiha RZ, Natov N, Glockenberg KS, Widmer J, Gaidhane M, Kahaleh M. Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit? Dig Dis Sci. 2014 Dec;59(12):3099-102. doi: 10.1007/s10620-014-3264-6. Epub 2014 Jul 18. PMID 25033929